Corresponding author at: Pneumology Department, Hospital Beatriz Ângelo, Av. Carlos Teixeira 3, 2674-514 Loures, Portugal.
was read the article
array:24 [ "pii" => "S2531043720301525" "issn" => "25310437" "doi" => "10.1016/j.pulmoe.2020.06.013" "estado" => "S300" "fechaPublicacion" => "2021-05-01" "aid" => "1519" "copyright" => "Sociedade Portuguesa de Pneumologia" "copyrightAnyo" => "2020" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Pulmonol. 2021;27:272-3" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:19 [ "pii" => "S253104372030101X" "issn" => "25310437" "doi" => "10.1016/j.pulmoe.2020.04.018" "estado" => "S300" "fechaPublicacion" => "2021-05-01" "aid" => "1487" "copyright" => "Sociedade Portuguesa de Pneumologia" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Pulmonol. 2021;27:273-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Acute colonic pseudo-obstruction causing Acute Respiratory Failure in Duchenne Muscular Dystrophy" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "273" "paginaFinal" => "276" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1551 "Ancho" => 900 "Tamanyo" => 81068 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">The radiograph of the chest and the upper abdomen of the two patients with Acute Colonic Pseudo-Obstruction (A<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>case 1; B<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>case 2).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "A. Vianello, G. Arcaro, S. Ferrarese, B. Molena, C. Giraudo" "autores" => array:5 [ 0 => array:2 [ "nombre" => "A." "apellidos" => "Vianello" ] 1 => array:2 [ "nombre" => "G." "apellidos" => "Arcaro" ] 2 => array:2 [ "nombre" => "S." "apellidos" => "Ferrarese" ] 3 => array:2 [ "nombre" => "B." "apellidos" => "Molena" ] 4 => array:2 [ "nombre" => "C." "apellidos" => "Giraudo" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S253104372030101X?idApp=UINPBA00004E" "url" => "/25310437/0000002700000003/v1_202105020809/S253104372030101X/v1_202105020809/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2531043720300805" "issn" => "25310437" "doi" => "10.1016/j.pulmoe.2020.04.006" "estado" => "S300" "fechaPublicacion" => "2021-05-01" "aid" => "1463" "copyright" => "Sociedade Portuguesa de Pneumologia" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Pulmonol. 2021;27:269-72" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:9 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Rifampicin-induced disseminated intravascular coagulation: An antibody-mediated side effect" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "269" "paginaFinal" => "272" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "G. Sousa, A. Carreiro, P. Duarte" "autores" => array:3 [ 0 => array:2 [ "nombre" => "G." "apellidos" => "Sousa" ] 1 => array:2 [ "nombre" => "A." "apellidos" => "Carreiro" ] 2 => array:2 [ "nombre" => "P." "apellidos" => "Duarte" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2531043720300805?idApp=UINPBA00004E" "url" => "/25310437/0000002700000003/v1_202105020809/S2531043720300805/v1_202105020809/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "A PI*MS is not always a PI*MS. An example of when genotyping for alpha-1 antitrypsin deficiency is necessary" "tieneTextoCompleto" => true "saludo" => "Dear Editor," "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "272" "paginaFinal" => "273" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "T. Martín, M. Miravitlles, S.T. Furtado" "autores" => array:3 [ 0 => array:4 [ "nombre" => "T." "apellidos" => "Martín" "email" => array:1 [ 0 => "teresamartinrioja@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "M." "apellidos" => "Miravitlles" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "S.T." "apellidos" => "Furtado" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Pneumology Department, Hospital Beatriz Ângelo, Loures, Portugal" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Pneumology Department, Hospital Universitari Vall d'Hebron, Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Barcelona Hospital Campus, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author at: Pneumology Department, Hospital Beatriz Ângelo, Av. Carlos Teixeira 3, 2674-514 Loures, Portugal." ] ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Alpha-1 antitrypsin (AAT) is a serum glycoprotein with functions which include neutrophil elastase inhibition in the lung (protecting it from destruction and emphysema), and antioxidant, anti-inflammatory, anti-infectious and immunomodulation effects. Alpha-1 antitrypsin deficiency (AATD) is an autosomal co-dominant disease and is considered one of the most frequent hereditary disorders; however, its epidemiology remains partially unknown owing to underdiagnosis.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> At least 60 deficient proteinase inhibitor* (PI*) alleles have been described, the most common being PI*S (5%–10% in Caucasians) and PI*Z (1%–3%), which are associated with reduced serum AAT levels of 40 an escalation plan and ceilings care and 10%–20%, respectively. PI*ZZ is the most frequent genotype (95%) among individuals with severe deficiency.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> Previous studies suggest that some areas of Portugal may have a very high frequency of deficient variants.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> Other deficient variants (non-S, non-Z) are considered as “rare” because of their low frequency, they cannot be identified by the usual allele-specific genotyping methods and cannot always be characterized by isoelectrofocusing (IEF) for phenotyping; therefore they can only be detected by molecular biology techniques, such as genome sequencing.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> Consequently, in cases with discordant plasma and phenotype results, it is important to continue diagnostic assessment since the identification of a severely deficient genotype supports the possible indication of augmentation therapy and the need for family screening.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">The PI*M<span class="elsevierStyleInf">Malton</span> variant is a rare deficient variant that differs from the normal M allele by deletion of the entire codon (TTC) for the residue Phe at position 51/52 (exon II). It is associated with severely reduced plasma AAT levels and hepatic inclusions by polymers and is characterized by a normal isoelectrophoretic pattern, which may be confounded with a normal M protein on IEF.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">Information about the frequency of rare alleles in Portugal is scarce. In a previous study including 1864 subjects, 9.5% of the AATD cases were related to a rare allele and null variants.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> The majority of rare alleles (n = 64; 15.3%) corresponded to PI*M<span class="elsevierStyleInf">Malton</span> and PI*M<span class="elsevierStyleInf">Palermo</span>, including n = 16 PI*SM<span class="elsevierStyleInf">Malton</span> (3.8% of the individuals with AATD). However, the study sample might not be representative of the whole country, because most of the samples had been collected in the North and Central regions of Portugal.</p><p id="par0020" class="elsevierStylePara elsevierViewall">Similarly, the PI*M<span class="elsevierStyleInf">Malton</span> variant is considered to be the second cause of severe AATD in Spain. A study including 3511 subjects over 12 years showed 1.6% of rare AAT variants, with PI*I (34%) and PI*M<span class="elsevierStyleInf">Malton</span> (20%) being the most frequent, accounting for 54% of all rare variants.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> PI*M<span class="elsevierStyleInf">Malton</span> allele was also very common among the rare variants in other countries: 60% in Tunisia, 35% in Italy (particularly in Sardinia), and 8% in Switzerland. However, it has not been found in Finland, and is rare in Ireland.<a class="elsevierStyleCrossRefs" href="#bib0020"><span class="elsevierStyleSup">4,5</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">Augmentation therapy is indicated in severely deficient patients (AAT serum levels < 57 mg/dL) associated with deficient genotypes, including PI*SZ.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Since M<span class="elsevierStyleInf">Malton</span> is associated with levels similar to the Z variant, patients with genotypes such as PI*M<span class="elsevierStyleInf">Malton</span>M<span class="elsevierStyleInf">Malton</span>, PI*ZM<span class="elsevierStyleInf">Malton</span>, PI*SM<span class="elsevierStyleInf">Malton</span> and PI*NullM<span class="elsevierStyleInf">Malton</span> may be candidates for augmentation therapy. Therefore, it is crucial to identify these genotypes in patients with clinical manifestations, low AAT serum levels and inconsistent phenotypes on IEF.</p><p id="par0030" class="elsevierStylePara elsevierViewall">We had the opportunity to treat the case of a 57-year-old man, ex-smoker of 40 pack-years, with severe chronic obstructive pulmonary disease (COPD) and extensive emphysema on computed tomography scan. He was diagnosed with severe AATD due to a serum AAT level of 46 mg/dL and fulfilled all criteria for augmentation therapy.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> However, the phenotype was reported as PI*MS. Due to the inconsistency between the plasma levels and phenotyping, genotyping was performed by SERPINA1 gene sequencing, showing a PI*SM<span class="elsevierStyleInf">Malton</span> genotype.</p><p id="par0035" class="elsevierStylePara elsevierViewall">This was an example of a patient with severe, early-onset emphysema with severe AATD defined by a serum level of AAT < 57 mg/dL, considered as the protective threshold, but with a PI*MS phenotype, consistent with a mild deficiency.</p><p id="par0040" class="elsevierStylePara elsevierViewall">The patient was referred for evaluation for lung transplantation, and in the meantime was considered for augmentation therapy with intravenous AAT.</p><p id="par0045" class="elsevierStylePara elsevierViewall">In conclusion, among the rare deficient variants of AAT, PI*M<span class="elsevierStyleInf">Malton</span> is probably the most frequent on the Iberian Peninsula, although it still represents a challenge because it is not detected by the first line diagnostic tests (phenotyping/allele-specific genotyping). An PI*M<span class="elsevierStyleInf">Malton</span> allele-specific genotyping assay has been developed for faster and cheaper diagnosis,<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> but it is not universally available. A larger registry database is needed for a better understanding of the characteristics and natural history of carriers of this rare variant.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a></p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflicts of interest</span><p id="par0050" class="elsevierStylePara elsevierViewall">Teresa Martin has received speaker fees from Menarini and GlaxoSmithKline. Marc Miravitlles has received speaker fees from AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, Menarini, Rovi, Bial, Sandoz, Zambon, CSL Behring, Grifols and Novartis, consulting fees from AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Bial, Gebro Pharma, Kamada, CSL Behring, Laboratorios Esteve, Ferrer, Mereo Biopharma, Spin Therapeutics, Verona Pharma, TEVA, pH Pharma, Novartis, Sanofi and Grifols and research grants from GlaxoSmithKline and Grifols. Sofia Tello Furtado has received speaker fees from AstraZeneca, Boehringer Ingelheim, Bial, Novartis, Boehringer Ingelheim, and GlaxoSmithKline.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Conflicts of interest" ] 1 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2020-05-18" "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:7 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Portuguese consensus document for the management of alpha-1-antitrypsin deficiency" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.P. Lopes" 1 => "M.A. Mineiro" 2 => "F. Costa" 3 => "J. Gomes" 4 => "C. Santos" 5 => "C. Antunes" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.pulmoe.2018.09.004" "Revista" => array:7 [ "tituloSerie" => "Pulmonology." "fecha" => "2018" "volumen" => "24" "numero" => "Suppl 1" "paginaInicial" => "1" "paginaFinal" => "21" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30473034" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Alpha-1 antitrypsin deficiency detection in a Portuguese population" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "L. Meira" 1 => "R. Boaventura" 2 => "S. Seixas" 3 => "M. Sucena" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1080/15412555.2017.1414779" "Revista" => array:6 [ "tituloSerie" => "COPD." "fecha" => "2018" "volumen" => "15" "numero" => "1" "paginaInicial" => "4" "paginaFinal" => "9" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Alpha-1-antitrypsin deficiency in Madeira (Portugal): the highest prevalence in the world" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "C. Spínola" 1 => "J. Bruges-Armas" 2 => "C. Pereira" 3 => "A. Brehm" 4 => "H. Spínola" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.rmed.2009.04.012" "Revista" => array:6 [ "tituloSerie" => "Respir Med." "fecha" => "2009" "volumen" => "103" "paginaInicial" => "1498" "paginaFinal" => "1502" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19450958" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Application of a diagnostic algorithm for the rare deficient variant Mmalton of alpha-1-antitrypsin deficiency: a new approach" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "I. Belmonte" 1 => "M. Barrecheguren" 2 => "R.M. López-Martínez" 3 => "C. Esquinas" 4 => "E. Rodríguez" 5 => "M. Miravitlles" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2147/COPD.S115940" "Revista" => array:6 [ "tituloSerie" => "Int J Chron Obstruct Pulmon Dis." "fecha" => "2016" "volumen" => "11" "paginaInicial" => "2535" "paginaFinal" => "2541" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27877030" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Rare alpha-1-antitrypsin variants: are they really so rare?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "F. Rodríguez-Frías" 1 => "M. Miravitlles" 2 => "R. Vidal" 3 => "S. Camos" 4 => "R. Jardí" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/1753465811434320" "Revista" => array:7 [ "tituloSerie" => "Ther Adv Respir Dis." "fecha" => "2012" "volumen" => "6" "numero" => "2" "paginaInicial" => "79" "paginaFinal" => "85" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22291048" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Rapid detection of Mmalton alpha-1-antitrypsin deficiency allele by real-time PCR and melting curves in whole blood, serum and dried blood spot samples" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "I. Belmonte" 1 => "L. Montoto" 2 => "M. Miravitlles" 3 => "M. Barrecheguren" 4 => "C. Esquinas" 5 => "E. Rodríguez" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1515/cclm-2015-0297" "Revista" => array:7 [ "tituloSerie" => "Clin Chem Lab Med." "fecha" => "2016" "volumen" => "54" "numero" => "2" "paginaInicial" => "241" "paginaFinal" => "248" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26154193" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Implementation of European Alpha-1 Research Collaboration (EARCO) in Portugal: the future starts now" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "M. Sucena" 1 => "J. Gomes" 2 => "C. Guimarães" 3 => "M. Miravitlles" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Pulmonology." "fecha" => "2020" "numero" => "Feb 10" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/25310437/0000002700000003/v1_202105020809/S2531043720301525/v1_202105020809/en/main.assets" "Apartado" => array:4 [ "identificador" => "72880" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/25310437/0000002700000003/v1_202105020809/S2531043720301525/v1_202105020809/en/main.pdf?idApp=UINPBA00004E&text.app=https://journalpulmonology.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2531043720301525?idApp=UINPBA00004E" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 October | 247 | 34 | 281 |
2024 September | 271 | 29 | 300 |
2024 August | 287 | 38 | 325 |
2024 July | 301 | 36 | 337 |
2024 June | 192 | 27 | 219 |
2024 May | 246 | 41 | 287 |
2024 April | 218 | 33 | 251 |
2024 March | 202 | 22 | 224 |
2024 February | 180 | 23 | 203 |
2024 January | 238 | 29 | 267 |
2023 December | 156 | 34 | 190 |
2023 November | 179 | 44 | 223 |
2023 October | 175 | 33 | 208 |
2023 September | 175 | 35 | 210 |
2023 August | 163 | 25 | 188 |
2023 July | 168 | 30 | 198 |
2023 June | 183 | 28 | 211 |
2023 May | 193 | 35 | 228 |
2023 April | 177 | 26 | 203 |
2023 March | 216 | 32 | 248 |
2023 February | 134 | 23 | 157 |
2023 January | 173 | 18 | 191 |
2022 December | 176 | 21 | 197 |
2022 November | 173 | 39 | 212 |
2022 October | 197 | 32 | 229 |
2022 September | 148 | 42 | 190 |
2022 August | 179 | 37 | 216 |
2022 July | 166 | 54 | 220 |
2022 June | 162 | 31 | 193 |
2022 May | 135 | 41 | 176 |
2022 April | 157 | 46 | 203 |
2022 March | 158 | 51 | 209 |
2022 February | 138 | 44 | 182 |
2022 January | 177 | 58 | 235 |
2021 December | 118 | 40 | 158 |
2021 November | 154 | 41 | 195 |
2021 October | 120 | 62 | 182 |
2021 September | 107 | 39 | 146 |
2021 August | 98 | 55 | 153 |
2021 July | 91 | 34 | 125 |
2021 June | 197 | 84 | 281 |
2021 May | 255 | 80 | 335 |
2021 April | 343 | 111 | 454 |
2021 March | 127 | 40 | 167 |
2021 February | 68 | 25 | 93 |
2021 January | 49 | 32 | 81 |
2020 December | 30 | 24 | 54 |
2020 November | 29 | 21 | 50 |
2020 October | 44 | 30 | 74 |
2020 September | 47 | 41 | 88 |
2020 August | 164 | 47 | 211 |
2020 July | 56 | 14 | 70 |